1. Home
  2. GHRS vs CTLP Comparison

GHRS vs CTLP Comparison

Compare GHRS & CTLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • CTLP
  • Stock Information
  • Founded
  • GHRS 2018
  • CTLP 1992
  • Country
  • GHRS Ireland
  • CTLP United States
  • Employees
  • GHRS N/A
  • CTLP N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • CTLP EDP Services
  • Sector
  • GHRS Health Care
  • CTLP Technology
  • Exchange
  • GHRS Nasdaq
  • CTLP Nasdaq
  • Market Cap
  • GHRS 774.1M
  • CTLP 776.5M
  • IPO Year
  • GHRS 2021
  • CTLP N/A
  • Fundamental
  • Price
  • GHRS $13.53
  • CTLP $10.56
  • Analyst Decision
  • GHRS Strong Buy
  • CTLP Hold
  • Analyst Count
  • GHRS 9
  • CTLP 4
  • Target Price
  • GHRS $29.33
  • CTLP $12.00
  • AVG Volume (30 Days)
  • GHRS 274.3K
  • CTLP 683.1K
  • Earning Date
  • GHRS 11-07-2025
  • CTLP 11-06-2025
  • Dividend Yield
  • GHRS N/A
  • CTLP N/A
  • EPS Growth
  • GHRS N/A
  • CTLP 473.33
  • EPS
  • GHRS N/A
  • CTLP 0.86
  • Revenue
  • GHRS N/A
  • CTLP $302,548,000.00
  • Revenue This Year
  • GHRS N/A
  • CTLP $18.25
  • Revenue Next Year
  • GHRS N/A
  • CTLP $12.30
  • P/E Ratio
  • GHRS N/A
  • CTLP $12.28
  • Revenue Growth
  • GHRS N/A
  • CTLP 12.64
  • 52 Week Low
  • GHRS $6.72
  • CTLP $7.01
  • 52 Week High
  • GHRS $20.50
  • CTLP $11.36
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 50.01
  • CTLP 41.25
  • Support Level
  • GHRS $12.50
  • CTLP $10.55
  • Resistance Level
  • GHRS $14.44
  • CTLP $10.61
  • Average True Range (ATR)
  • GHRS 1.04
  • CTLP 0.05
  • MACD
  • GHRS 0.01
  • CTLP 0.00
  • Stochastic Oscillator
  • GHRS 45.24
  • CTLP 7.14

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About CTLP Cantaloupe Inc.

Cantaloupe Inc is a technology leader powering self-service commerce by offering one integrated solution for payments processing, logistics, and back-office management. The group offers a comprehensive suite of solutions, including micro-payment processing, self-checkout kiosks, mobile ordering, connected point-of-sale (POS) systems, and enterprise cloud software. Its product and services portfolio consists of Card Readers, Self-Service Kiosks, Smart Coolers, Seed Pick Easy, Cantaloupe Go, Cheq, Smart Lock Connect, and Vine Digital Studio. The company derives revenue streams from subscriptions, transaction processing, and equipment sales.

Share on Social Networks: